Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.410
+0.010 (0.71%)
At close: Aug 26, 2026, 4:00 PM EDT
1.410
0.00 (-0.02%)
After-hours: Aug 26, 2026, 7:54 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $478.15 million as of August 26, 2026. Its market cap has increased by 47.21% in one year.
Market Cap
478.15M
Enterprise Value
466.08M
1-Year Change
47.21%
Ranking
Category
Stock Price
$1.41
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $478.15M, an increase of 1,360.01%. That is a compound annual growth rate of 47.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 478.15M | 13.40% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 503.74M |
| Evommune | 500.47M |
| Relmada Therapeutics | 489.61M |
| Q32 Bio | 485.84M |
| Eupraxia Pharmaceuticals | 485.68M |
| Prothena Corporation | 483.59M |
| Capricor Therapeutics | 481.97M |
| Puma Biotechnology | 481.10M |